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Abstract
Background: Globally, erectile dysfunction burden (ED) is rising appreciably and it is projected to affect about 332
million men by the year 2025. This rise is attributable to the rising incidence of conditions associated with ED
including obesity, diabetes, hypertension, coronary artery disease and depression. We conducted this
community-based screening to elucidate on the prevalence of ED and its associated factors among men residing in
an urban community in Tanzania.
Methods: We conducted a cross-sectional community-based study and interviewed 441 men aged at least
18 years. Diabetes and hypertension were defined as per the International Diabetes Federation (IDF) and the 7th
Report of the Joint National Committee (JNC 7) respectively. The 5-item version of the International Index of Erectile
Function (IIEF-5) Scale was used to assess for erectile dysfunction. Multivariate logistic regression analyses were
performed to explore the factors associated with ED.
Results: The mean age was 47.1 years, 57.6 % had excess body weight, 8.2 % had diabetes and 61.5 % had high
blood pressure. Overall, 24 % (106/441) of men in this study had some form of ED. Participants with age ≥55,
positive smoking history, obesity, diabetes and hypertension displayed highest rates of ED in their respective
subgroups. However, age ≥40 and diabetes were ultimately the strongest factors for ED after multivariate logistic
regression analyses, (OR 5.0, 95 % CI 2.2–11.2, p < 0.001 and OR 5.3, 95 % CI 2.2–12.7, p < 0.001 respectively).
Conclusion: Erectile dysfunction affects about a quarter of adult men living in Kinondoni district. Old age, obesity,
smoking, hypertension and diabetes have the potential to increase the odds of ED up-to 5 times. In view of this,
men with diabetes and hypertension should be offered screening services and treatment of ED as an integral
component in their management.
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Plain English summary
Erectile dysfunction (ED) is defined as persistent inabil-
ity to attain and/or maintain an erection sufficient for
satisfactory sexual activity. ED is associated with old age
and comorbidities including diabetes and hypertension
amongst others. The incidence of ED is increasing
globally and this is attributed to the aging population
and the increase in the incidence of diabetes and hyper-
tension. We aimed to determine the burden of ED
among male residents of Kinondoni district, Dar es
Salaam Tanzania. We recruited and interviewed 441
men aged at least 18 years. We utilized the 5-item
version of the International Index of Erectile Function
(IIEF-5) Scale for erectile dysfunction assessment. We
defined diabetes and hypertension according to the
International Diabetes Federation and the 7th Report of
the Joint National Committee (JNC 7) respectively.
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About a quarter of all men had some form of ED. Old
age and diabetes were associated with a 5 times
increased likelihood for having ED. We concluded that
ED is a common problem among men of reproductive
age and that men particularly those with diabetes and
hypertension should be offered screening services and
treatment of ED as an integral component in their
management.
Background
Erectile dysfunction (ED) is defined as persistent inability
to attain and/or maintain an erection sufficient for satis-
factory sexual activity [1]. Despite its benign nature, ED
has the potential to impair personal interactions, quality
of life and well-being of both patients and their partners
[2–4]. The rates of ED increase with age almost always
indicating endothelial dysfunction [5–14]. Furthermore,
ED is associated with a number of medical conditions or
their treatment including diabetes mellitus, hypertension,
coronary artery disease and depression [15–22].
Establishing the burden of ED in the community is
challenging and most clinicians lack adequate skills in
detecting and/or managing it [23, 24]. The reported
rates worldwide have a wide variability ranging between
2 % and 90 % depending on the age, race, comorbidities,
hospital- versus community-based, assessment tool, and
geographical location of the population studied [6–8, 12,
25–38]. With the rising of comorbidities associated with
ED worldwide, it is projected that its incidence will rise
appreciably and that by year 2025, 332 million men will
have some form of ED [39]. Similar to other developing
nations, Tanzania is also witnessing an upsurge of non-
communicable diseases with ED as an inevitable compli-
cation. Little is known about the community burden of
ED in Tanzania. To elucidate on the prevalence of ED
and its associated factors in a Tanzanian community we
undertook this cross-sectional study among Kinondoni
district men.
Methods
Study procedures & definition of terms
We conducted this 4-days community-based cross-
sectional screening among men residing in Kinondoni
district, Dar es Salaam, Tanzania in January 2016. Four
hundred forty-one men of African descent aged at least
18 years were recruited and screened for erectile
dysfunction. Participants were consented to participate
in the study after they voluntarily came to the screening
grounds for an organized general health check-up. Inter-
viewers, mainly clinicians and nurses from the Jakaya
Kikwete Cardiac Institute (JKCI) and Mwananyamala
District Hospital were recruited and trained to adminis-
ter the questionnaire and perform anthropometric,
blood pressure (BP) and random/fasting blood glucose
(RBG/FBG) measurements. Weight and height were
measured with standard scales and BMI was calculated
by a ratio of weight (in kilograms) to height (in meters)
squared. WHO BMI cut-off values were used to define
underweight, normal, overweight and obese [40]. Smok-
ing history was sought and participants were categorized
as current, past or a never smoker. Diabetes was diag-
nosed using RBG ≥11.1 mmol/L and/or FBG ≥7 mmol/L
[41]. Prediabetes was defined as FBG of 5.6–6.9 mmol/L
and/or RBG of 7.8–11.0 mmol/L [41]. Blood pressure
was measured by digital BP machines where a systolic
blood pressure (SBP) <120 mmHg and a diastolic blood
pressure (DBP) <80 mmHg defined normotension. Pre-
hypertension was defined by SBP of 120–139 mmHg or
DBP of 80–89 mmHg, while SBP ≥140 mmHg or DBP
≥90 mmHg indicated hypertension [42]. The validated
Swahili-translated 5-item version of the International
Index of Erectile Function (IIEF-5) Scale was used to
assess for erectile dysfunction [43–46]. The IIEF-5 Scale
categorizes ED into five categories depending on the
score i.e. 22–25: no ED, 17–21: mild ED, 12–16: mild to
moderate ED, 8–11: moderate ED, 5–7: severe ED.
Sample size calculations and recruitment process
This study was conducted in Kinondoni district which has
an adult (≥18 years) population of about 1.633 million,
48.5 % of whom are males. Overall, we aimed to screen
(for hypertension and diabetes) a number representing at
least 0.1 % of the district’s total population i.e. ≥1633
persons. As this was the first local community-based study
intending to investigate on the burden of ED, the authors
hypothesized the prevalence to be 50 % and so it was pre-
determined that a minimum of 396 men (i.e. 50 % of the
estimated 792/1633 men to be interviewed) will be
assessed for ED. However, we exceeded the target and
screened 1826 persons of whom 882 (48.3 %) were males.
Our new minimum target for ED screening was then
raised to 441 (i.e. 50 % of the recruited 882/1826 men),
which is the exact number that comprised this study.
Statistical analysis
Continuous variables are summarized and presented as
means (± SD) while categorical variables are displayed as
frequencies (percentages). Chi square tests and Student’s
T-test were used in comparison of categorical and
continuous variables respectively. Bivariate analyses were
performed to determine factors associated with ED.
Significant factors on bivariate analysis were included in a
logistic regression model to control for confounders. Odd
ratios with 95 % confidence intervals and p-values are
reported. STATA v.11.0 was used for analysis, significance
was set at p < 0.05 and all analyses were two-sided.
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Results
Socio-demographic and clinical characteristics of 441
study participants is displayed in Table 1. The mean age
was 47.1 (±15.4) years and 63.7 % were aged 40 years
and above. 53.8 % had completed primary school, 71 %
were married, and 14 % ever smoked. The mean BMI
was 26.6 (±5.3) kg/m2 and 57.6 % of individuals had
excess body weight (i.e. BMI ≥25). The mean blood
glucose level was 6.1 (±2.2) mmol/L and 8.2 % had type-
2 diabetes mellitus. The mean SBP and DBP were 146
(±32) mmHg and 91 (±20) mmHg respectively and
61.5 % had hypertension.
Overall, 24 % (106/441) of men in this study had some
form of ED. Of these, 9(8.5 %) had the mild form, 24
(22.6 %) mild-moderate form, 40 (37.8 %) moderate
form, and 33 (31.1 %) had the severe form. Prevalence of
ED increased with increase in age and weight i.e. 37 %
and 32 % of those aged ≥55 and obese respectively had
ED compared to 10.6 % and 18.1 % among those aged
18–39 years and normal BMI, (p < 0.001 and p < 0.01 re-
spectively), Fig. 1. Men with a positive smoking history
had a 40 % increased likelihood for ED compared to
never smokers, (OR 1.4, 95%CI 0.7–2.5, p > 0.05). 63 %
of men with diabetes had ED compared to 30.4 % with
prediabetes and 19.1 % with normal blood glucose, (p <
0.01 and p < 0.001 respectively). Participants with prehy-
pertension (20.2 %) and hypertension (29.3 %) had
significantly higher ED rates compared to normotensive
persons (8.3 %), p < 0.05 and p < 0.001 respectively.
Six variables including age, BMI, physical activity,
smoking, hypertension, and diabetes status underwent
bivariate analyses to assess if they have associations with
ED. Four variables including age, BMI, hypertension and
diabetes status revealed significant associations and these
were added in a logistic regression model for further
analysis. Table 2 displays results of multivariate logistic
regression analysis. Men aged 40 years and above
displayed a 5 times increased likelihood of having ED
compared to those younger than 40 years, (OR 5.0, 95 %
CI 2.2–11.2, p < 0.001). Likewise, diabetes was associated
with a 5 times increased odds of having ED, (OR 5.3,
95 % CI 2.2–12.7, p < 0.001).
Discussion
Nearly a quarter of men in this present study had ED
with over two-thirds exhibiting the moderate to severe
form. Our findings are close to a Chinese study by Bai et
al. which produced a prevalence of 28.3 % [47]. A wide
variability in the prevalence of ED from 13.2 % [48] in
Egypt to 51.3 [25] in Singapore observed among studies
[12, 25, 40, 49] is largely a result of variabilities in popu-
lation characteristics and tools used for ED assessment
among studies. Old age has been consistently shown to
be a strong predictor of ED [25]. In this study, the rate
of ED among participants aged 55 and above was three
times compared to those in the age group 18–39 years.
These findings echo the results of a landmark Massa-
chusetts Male Aging Study [25] among others [2, 18,
29]. Aging is associated with comorbidities resulting into
atherosclerosis and ultimately vascular dysfunction with
ED as one of the manifestations [50].
Obesity was significantly associated with ED on bivari-
ate analyses in this study. Such findings are in unison
with Moreira [12] et al. study in which obesity proved to
be a significant predictor on bivariate analysis but lost
its significance after multivariate analysis. A study by
Table 1 Socio-Demographic & Clinical Characteristics of Study
Participants (N = 441)
Characteristic n (%)
Age groups
18–39 160 (36.3 %)
40–54 135 (30.6 %)
≥ 55 146 (33.1 %)
Education level
None 12 (02.7 %)
Primary 237 (53.8 %)
Secondary 139 (31.5 %)
University 53 (12.0 %)
Marital status
Single 95 (21.6 %)
Married 313 (71.0 %)
Divorced 24 (05.4 %)
Widowed 9 (02.0 %)
Smoking status
Non-smoker 379 (86.0 %)
Current smoker 9 (02.0 %)
Past smoker 53 (12.0 %)
BMI status
Underweight 14 (03.2 %)
Normal 173 (39.2 %)
Overweight 154 (35.0 %)
Obese 100 (22.6 %)
Blood Sugar Range
Normal 344 (77.9 %)
Prediabetes 61 (13.9 %)
Diabetes 36 (08.2 %)
Blood Pressure Range
Normal 60 (13.6 %)
Prehypertension 110 (24.9 %)
Hypertension 271 (61.5 %)
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Chung et al [51] showed that obesity is not an under-
lying factor for ED per se, but it does increase the risk
through development of chronic vascular disease.
Numerous studies [12, 50, 52–55] have suggested a dose
dependent relationship between smoking and ED. Ever
smokers in this study had a 40 % increased likelihood
for ED compared to never smokers. A systematic review
by Cao [55] et al. found that ED was increased by 20 %
and 51 % among past- and current-smokers respectively.
Apart from its potential to cause direct toxic effects on
the vascular endothelium, smoking is linked to ED
through its potential to mediate systemic changes in-
cluding hypercoagulability, platelet aggregation and
thromboxane-prostacyclin imbalance [56].
Diabetes is a well-established factor for ED. Partici-
pants with diabetes in our study had a 5 times increased
odds for ED (OR 5.3) compared to diabetes-free persons.
These current results have replicated the findings of a
study by Zedan [57] et al. among Egyptian men which
found an odds of 5.4. Other studies have consistently
produced higher ED rates among diabetics compared to
diabetes-free persons ranging between 35 % and 75 % [8,
11, 12, 25, 39, 58–63]. Diabetes is a risk factor for ED
through its potential for causing autonomic neuropathy,
gonadal dysfunction, and vascular and neurogenic
impairment of penile smooth muscle [59, 64, 65]. Hyper-
tensive participants had a tripled likelihood of having ED
compared to their normotensive counterparts (p < 0.001),
however the significance was lost after multivariate logistic
analyses. Hypertension and some antihypertensive drugs
have been shown to increase the risk for ED [17, 29]. High
blood pressure is known to interfere with blood flow to
the corpora cavernosa by causing narrowing and loss of
elasticity of arteries thus resulting to ED [66].
Other factors including heavy alcohol consumption [2,
52], depression [18, 67–69], and low economic status
[18, 70, 71] have been associated with increased risk for
ED but were beyond the scope of this study. Further
studies on ED in this area could investigate on their
association with ED among Tanzanian men.
This study has several strengths including; (i) the use of
an internationally recognized tool for assessing ED that
will make comparison with other studies feasible, (ii) the
simultaneous assessment of obesity, diabetes and hyper-
tension allowed us to confirm the presence of these risk
factors rather than relying on participants’ self-report. This
study has some limitations as well, including; (i) the
generalizability of our findings may be limited because the
men screened in this study voluntarily came for screening
Fig. 1 Prevalence of ED by Age, BMI, Diabetes and Hypertension status
Table 2 Multivariate Logistic Regression Analysis of Factors
Associated with ED
Test group Comparative group OR 95 % CI P-value
Age ≥40 Age < 40 5.0 2.2–11.2 <0.001
BMI ≥30 BMI <30 1.4 0.7–2.5 0.306
Hypertensive Non-hypertensive 1.2 0.6–2.3 0.541
Diabetic Non-diabetic 5.3 2.2–12.7 <0.001
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and this might reflect a selected population of those either
with a very good health seeking behavior or those having
some health concerns necessitating medical help, (ii) Our
assessment of ED was through interviews and we are
aware that conditions like ED are highly associated with
social stigmas. As a result of this, it is likely that ED was
underreported by study participants, (iii) we made diagno-
ses of hypertension and diabetes based on a single point
measurement of BP and RBG/FBG, thus our diabetes and
hypertension rates might be overestimated, and (iv) our
study was prone to several forms of bias including selec-
tion bias and non-differential bias, inevitably due to its
cross-sectional nature.
Conclusions
Several conclusions can be drawn from this present
study: (i) ED affects one in four men over 18 years in
Kinondoni district, (ii) age and diabetes mellitus are the
strongest factors associated with ED, (iii) the high rates
of ED among hypertensive and diabetic patients suggest
that patients with such comorbidities should be screened
for ED, (iv) with the increasing incidence of obesity,
hypertension, diabetes and an aging population, ED may
become a significant public health problem. In view of
these findings: (i) services for diagnosis and treatment of
ED should be incorporated in diabetes and hypertension
clinics particularly in the developing world, and (ii)
health programs should be designed in developing
nations to educate and empower individuals on healthy
eating, physical activeness and health seeking behavior.
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